Trading Signals: TXG Stock Price Prediction and Forecast (Thu. Sep. 12, 2019 - Fri. Dec. 22, 2023)(10x Genomics, Inc.)
| TXG latest price $151.0400 (4.28%) ($143.4400 - $153.2700) on Thu. Dec. 30, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.35% (three month average) | RSI | 56 | Latest Price | $151.0400(4.28%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | TXG advances 0.7% a day on average for past five trading days. | Weekly Trend | TXG advances 2.3% a week on average for past two weeks. | Market Behavior | Growth stock sell-off for large cap. Normal for small cap. | Correlated ETFs | Broad market will support TXG advance at 0% a week (0% probability) XBI(65%) VUG(63%) XLY(63%) SKYY(62%) VT(62%) | Factors Impacting TXG price | TXG will decline at least -1.675% in a week (0% probabilities). VIXM(-41%) UUP(-31%) TBT(-15%) VXX(-11%) UNG(1%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.675% (StdDev 3.35%) | Hourly BBV | 1.3 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $146.1(3.38%) | 10 Day Moving Average | $144.37(4.62%) | 20 Day Moving Average | $143.28(5.42%) | To recent high | -17% | To recent low | 10.9% | Market Cap | $15.143b | | | | 10X Genomics, Inc. is a life science technology company, which engages in building products to interrogate, understand and master biology. Its integrated solutions include single cell transcriptomics, single cell genomics, single cell epigenomes, linked-reads genomics and spatial transcriptomics. The company’s products include Single Cell Gene Expression, Immune Profiling, CNV, ATAC, and Genome and Exome. 10X Genomics was founded by Serge Saxonov, Ben Hindson, Kevin D. Ness and Eduard Diviu Terradas on July 2, 2012 and is headquartered in Pleasanton, CA. |